Inverness Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $14.4M | Buy |
28,469
+202
| +0.7% | +$102K | 0.8% | 37 |
|
|
2022
Q2 | $15.4M | Sell |
28,267
-5,927
| -17% | -$3.22M | 0.86% | 33 |
|
|
2022
Q1 | $20.2M | Sell |
34,194
-267
| -0.8% | -$158K | 0.9% | 32 |
|
|
2021
Q4 | $23M | Buy |
34,461
+737
| +2% | +$492K | 0.85% | 33 |
|
|
2021
Q3 | $19.3M | Buy |
33,724
+289
| +0.9% | +$165K | 0.71% | 37 |
|
|
2021
Q2 | $16.9M | Sell |
33,435
-32,304
| -49% | -$16.3M | 0.61% | 42 |
|
|
2021
Q1 | $30M | Buy |
65,739
+10,348
| +19% | +$4.72M | 1.24% | 29 |
|
|
2020
Q4 | $25.8M | Buy |
55,391
+16,344
| +42% | +$7.61M | 1.05% | 33 |
|
|
2020
Q3 | $17.2M | Sell |
39,047
-18,935
| -33% | -$8.36M | 0.77% | 35 |
|
|
2020
Q2 | $21M | Sell |
57,982
-4,274
| -7% | -$1.55M | 1.05% | 31 |
|
|
2020
Q1 | $17.7M | Sell |
62,256
-109,103
| -64% | -$30.9M | 1.11% | 30 |
|
|
2019
Q4 | $55.7M | Buy |
171,359
+62,165
| +57% | +$20.2M | 2.63% | 9 |
|
|
2019
Q3 | $31.8M | Buy |
109,194
+80,639
| +282% | +$23.5M | 1.65% | 23 |
|
|
2019
Q2 | $8.39M | Sell |
28,555
-132,814
| -82% | -$39M | 0.43% | 47 |
|
|
2019
Q1 | $44.2M | Buy |
161,369
+25,089
| +18% | +$6.87M | 2.41% | 12 |
|
|
2018
Q4 | $30.5M | Buy |
136,280
+82,096
| +152% | +$18.4M | 2.04% | 17 |
|
|
2018
Q3 | $13.2M | Buy |
+54,184
| New | +$13.2M | 0.7% | 38 |
|